[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350319-105":59,"doc-detail-350319-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","comprehensive-pan-cancer-analysis-of-fscn1-a-marker-for-prognosis-and-immunity","Comprehensive pan-cancer analysis of FSCN1 - A marker for prognosis and immunity","","Fascin actin-bundling protein 1 (FSCN1) is an actin cytoskeletal gene implicated in migration, motility, adhesion, and broader tumor-related cellular interactions. No systematic pan-cancer study previously unified its diagnostic, prognostic, and immunological predictive value. Using multiple public cancer and protein databases plus bioinformatics and single-cell and immune-focused analyses, the study also performed protein–protein interaction and gene set enrichment work, followed by experimental validation of proliferation and apoptosis effects.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-pan-cancer-analysis-of-fscn1-a-marker-for-prognosis-and-immunity/350319/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-pan-cancer-analysis-of-fscn1-a-marker-for-prognosis-and-immunity/350319.png","ImageObject",300,407,{"name":92,"@type":93},"Terk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What biological processes are linked to FSCN1 in cancer?","Question",{"text":113,"@type":114},"FSCN1 is associated with cell migration, motility, adhesion, and contributes to actin-based cellular structures and interactions relevant to tumor behavior.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which data sources and analyses were used to study FSCN1 across cancers?",{"text":118,"@type":114},"The study used UCSC Xena, TCGA, GTEx, HPA, cBioPortal, STRING, CancerSEA, and GDSC, applying bioinformatics to assess clinicopathologic associations, prognosis, genetic alterations, immune patterns, DNA methylation, single-cell functions, and drug sensitivity.",{"name":120,"@type":111,"acceptedAnswer":121},"What experimental findings support FSCN1’s role in mesothelioma?",{"text":122,"@type":114},"FSCN1 knockdown inhibited proliferation and induced apoptosis in mesothelioma, supported by CCK-8 and flow-cytometry apoptosis assays.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350319,1790194126,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Xu etal. Discover Oncology (2026) 17:763 [https://doi.org/10.1007/s12672-026-04949-7](https://doi.org/10.1007/s12672-026-04949-7)  \nDiscover Oncology  \nRESEARCH Open Access  \nComprehensive pan-cancer analysis of FSCN1  as a marker for prognosis and immunity  \nRui Xu1†, Wanxin Xu2†, Changqing Dong3 and Guangliang Qiang3*  \n†Rui Xu andWanxin Xu have contribute equally to this work.  \n*Correspondence:  \nGuangliang Qiang [pkudd@bjmu.edu.cn](pkudd@bjmu.edu.cn)[ ](pkudd@bjmu.edu.cn)1Department of Nuclear Medicine, China–Japan Friendship Hospital, No. 2 Yinghua East Street, Chaoyang District, Beijing 100029, China 2Peking University Aerospace School of Clinical Medicine, Aerospace Center Hospital, No.15 Yuquan Road, Haidian District, Beijing 100049, China 3Department of Thoracic Surgery, Peking University Third Hospital, No.49 Huayuan North Road, Haidian District, Beijing  \n100191, China  \nAbstract  \nBackground Fascin actin-bundling protein 1 (FSCN1), a member of actin cytoskeletal protein family genes, plays critical roles in cell migration, motility, adhesion, and other cellular interactions. It has shown its ascending importance in tumors of multiple systems, including the nervous system, respiratory system, digestive system and urinary system. Nevertheless, no systematic pan-cancer analysis has been carried out to investigate its function in diagnosis, prognosis, and immunological prediction. Methods We used UCSC Xena, The Cancer Genome Atlas (TCGA), Genotype Tissue Expression Project (GTEx), Human Protein Atlas (HPA), cBioPortal, STRING, Cancer single-cell state Atlas (CancerSEA), Genomics of Drug Sensitivity in Cancer (GDSC) and Xiantao Academic analysis tool websites and databases for the extraction of pancancer data on FSCN1 . We adopted bioinformatics methods to explore the potential role of FSCN1 in pan-cancer, including analysis of the correlation between FSCN1 and clinicopathologic features, prognosis, genetic alteration, immune, DNA methylation, single cell function and drug sensitivity. Furthermore, a protein–protein interaction network was drawn, and gene set enrichment analysis was conducted to explore the functions of FSCN1 . Finally, we validated the effects of FSCN1 on cell proliferation and apoptosis through experiments.  \nResults The findings ofthe comprehensive pan-cancer analysis revealed that FSCN1 was highly expressed in most cancers, except in acute myeloid leukemia, prostate adenocarcinoma and thyroid carcinoma, and it has a certain diagnostic and prognosis value in many cancers. Furthermore, FSCN1 expression was found to correlate with immune cell infiltration, immune checkpoint (ICP) genes expression, DNA methylation and drug sensitivity in a variety of cancers. In addition, we discovered that FSCN1 participated in the proliferation and DNA repair at the single-cell level. Besides, Gene function enrichment analyses revealed that genes that were co-expressed with FSCN1 were enriched within the actin filament regulation pathways. CCK-8 assay and flow cytometry apoptosis assay results indicated that FSCN1 knockdown inhibited proliferation and induced apoptosis in mesothelioma (MESO) .  \nConclusion FSCN1 is a prospective marker for the diagnosis, prognosis, immunology, chemotherapy, and small molecular drugs targeted for pan-cancer treatment. Keywords FSCN1, Pan-cancer, Diagnosis, Prognosis, Immunization  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are inclu","cbCaisKVnyjLWNDC","https://ap.wps.com/l/cbCaisKVnyjLWNDC","pdf",3674490,22,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What biological processes are linked to FSCN1 in cancer?\",\"answer\":\"FSCN1 is associated with cell migration, motility, adhesion, and contributes to actin-based cellular structures and interactions relevant to tumor behavior.\"},{\"question\":\"Which data sources and analyses were used to study FSCN1 across cancers?\",\"answer\":\"The study used UCSC Xena, TCGA, GTEx, HPA, cBioPortal, STRING, CancerSEA, and GDSC, applying bioinformatics to assess clinicopathologic associations, prognosis, genetic alterations, immune patterns, DNA methylation, single-cell functions, and drug sensitivity.\"},{\"question\":\"What experimental findings support FSCN1’s role in mesothelioma?\",\"answer\":\"FSCN1 knockdown inhibited proliferation and induced apoptosis in mesothelioma, supported by CCK-8 and flow-cytometry apoptosis assays.\"}]","Comprehensive pan-cancer analysis of FSCN1 - A marker for prognosis and immunity | PDF",1790088428,55,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf4b0d6c263c66a39b449708e79305bd.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14338911fbbcf791c38013bcdeb6ebf3.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4411f8f45cf574b2e52882dd51db16ee.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb222149c97baa194c19cc258f9083ed.webp",980,1306]